Urinary parabens and breast cancer risk: Modification by LINE-1 and LUMA global DNA methylation, and associations with breast cancer defined by tumor promoter methylation status
- PMID: 35975911
- PMCID: PMC9588525
- DOI: 10.1002/mc.23456
Urinary parabens and breast cancer risk: Modification by LINE-1 and LUMA global DNA methylation, and associations with breast cancer defined by tumor promoter methylation status
Abstract
Parabens are a group of alkyl esters of p-hydroxybenzoic acid added to consumer products to prevent the growth of harmful bacteria and molds. Parabens are hypothesized to increase the risk of breast cancer (BC); however, no study has examined the interactions between parabens, global DNA methylation (DNAm), and BC risk. We examined the modifying effects of DNAm on the associations between parabens and BC, and whether parabens were associated with BC defined by tumor promoter methylation status. Participants included 708 cases and 598 controls from the Long Island Breast Cancer Study Project. Methylparaben (MPB), propylparaben, and butylparaben levels were measured in spot urine samples. Global DNAm was measured by analysis of long interspersed elementes-1 (LINE-1) and the luminometric methylation assay (LUMA). The promoter methylation status of 13 genes was measured in tumor samples from 509 cases. We used logistic regression to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for the associations between parabens and BC stratified by LINE-1/LUMA, and between parabens and gene-specific promoter methylation-defined BC. Outcome heterogeneity was evaluated using ratios of ORs (RORs). We assessed the joint effects of the multiple parabens using quantile g-computation. The highest versus lowest tertile of MPB and a one-quantile increase in all parabens were associated with ORs of 1.46 (95% CI = 0.96-2.23) and 1.32 (95% CI = 1.02-1.71), respectively, among women with hypomethylated LINE-1. A one-ln unit increase in MPB was associated with a 25% increase in the odds of hypomethylated (vs. hypermethylated) CCND2 promoter-defined BC (ROR = 1.25, 95% CI = 1.06-1.48), and a one-quantile increase in all parabens was associated with a 55% increase in the odds of hypomethylated (vs. hypermethylated) CCND2 promoter-defined BC (ROR = 1.55, 95% CI = 1.04-2.32). Exposure to parabens may increase the risk of BC among women with hypomethylated global DNAm and may increase the risk of tumors with gene-specific hypomethylated promoter regions.
Keywords: DNA methylation; breast cancer; endocrine disrupting chemicals; gene promoter methylation; parabens.
© 2022 The Authors. Molecular Carcinogenesis published by Wiley Periodicals LLC.
Conflict of interest statement
Dr. Neugut has consulted for Otsuka, GlaxoSmithKline, Eisai, Hospira, and United Biosource Corp., and has grant support from Otsuka. He serves on the medical advisory board of EHE Intl. The remaining authors declare no conflict of interest.
Similar articles
-
Sources of polycyclic aromatic hydrocarbons are associated with gene-specific promoter methylation in women with breast cancer.Environ Res. 2016 Feb;145:93-100. doi: 10.1016/j.envres.2015.11.033. Epub 2015 Dec 6. Environ Res. 2016. PMID: 26671626 Free PMC article.
-
Final amended report on the safety assessment of Methylparaben, Ethylparaben, Propylparaben, Isopropylparaben, Butylparaben, Isobutylparaben, and Benzylparaben as used in cosmetic products.Int J Toxicol. 2008;27 Suppl 4:1-82. doi: 10.1080/10915810802548359. Int J Toxicol. 2008. PMID: 19101832
-
Polycyclic aromatic hydrocarbon (PAH)-DNA adducts and breast cancer: modification by gene promoter methylation in a population-based study.Cancer Causes Control. 2015 Dec;26(12):1791-802. doi: 10.1007/s10552-015-0672-7. Epub 2015 Sep 25. Cancer Causes Control. 2015. PMID: 26407953 Free PMC article.
-
A review of the endocrine activity of parabens and implications for potential risks to human health.Crit Rev Toxicol. 2005 Jun;35(5):435-58. doi: 10.1080/10408440490920104. Crit Rev Toxicol. 2005. PMID: 16097138 Review.
-
Minireview: Parabens Exposure and Breast Cancer.Int J Environ Res Public Health. 2022 Feb 8;19(3):1873. doi: 10.3390/ijerph19031873. Int J Environ Res Public Health. 2022. PMID: 35162895 Free PMC article. Review.
Cited by
-
Associations between phenol and paraben exposure and the risk of developing breast cancer in adult women: a cross-sectional study.Sci Rep. 2025 Feb 3;15(1):4038. doi: 10.1038/s41598-025-88765-z. Sci Rep. 2025. PMID: 39900803 Free PMC article.
-
Epigenetic Mechanisms of Endocrine-Disrupting Chemicals in Breast Cancer and Their Impact on Dietary Intake.J Xenobiot. 2024 Dec 24;15(1):1. doi: 10.3390/jox15010001. J Xenobiot. 2024. PMID: 39846533 Free PMC article. Review.
-
Association between Urinary Phenols and Parabens as Well as Breast Cancer.Iran J Public Health. 2025 Mar;54(3):634-644. doi: 10.18502/ijph.v54i3.18257. Iran J Public Health. 2025. PMID: 40330200 Free PMC article.
References
-
- Ocaña‐González JA, Villar‐Navarro M, Ramos‐Payán M, Fernández‐Torres R, Bello‐López MA. New developments in the extraction and determination of parabens in cosmetics and environmental samples. A review. Anal Chim Acta. 2015;858:1‐15. - PubMed
-
- Davidson PM, Branden AL. Antimicrobial activity of non‐halogenated phenolic compounds. J Food Prot. 1981;44:623‐632. - PubMed
-
- Seo JE, Kim S, Kim BH. In vitro skin absorption tests of three types of parabens using a Franz diffusion cell. J Expo Sci Environ Epidemiol. 2017;27:320‐325. - PubMed
-
- Abbas S, Greige‐Gerges H, Karam N, Piet MH, Netter P, Magdalou J. Metabolism of parabens (4‐hydroxybenzoic acid esters) by hepatic esterases and UDP‐glucuronosyltransferases in man. Drug Metab Pharmacokinet. 2010;25:568‐577. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical